Global Transthyretin Amyloidosis (Attr) Market Research Report 2025(Status and Outlook)
Report Overview
Transthyretin Amyloidosis (ATTR) is an autosomal dominant hereditary disease that occurs due to deposition of variant TTR (transthyretin) protein in humans. It is mainly characterized into two main types i.e. Hereditary ATTR (hATTR) and Wild-Type (wt) ATTR. While Hereditary ATTR is caused by point mutations within TTR allele, wild-type ATTR is caused by the misfolding of Wild-Type TTR. Major prevalence of Hereditary ATTR is observed in the 7MM, and this type has been further sub-classified into Familial Amyloidosis Polyneuropathy (FAP) and Familial Amyloidosis Cardiomyopathy (FAC).
The global Transthyretin Amyloidosis (Attr) market size was estimated at USD 3580.42 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Transthyretin Amyloidosis (Attr) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Transthyretin Amyloidosis (Attr) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Transthyretin Amyloidosis (Attr) market
Global Transthyretin Amyloidosis (Attr) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Corino Therapeutics
Proclara Bioscience
Arcturus Therapeutics
Market Segmentation (by Type)
Hereditary ATTR (HATTR)
Wild-Type (WT) ATTR
Market Segmentation (by Application)
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Transthyretin Amyloidosis (Attr) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Transthyretin Amyloidosis (Attr), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Transthyretin Amyloidosis (ATTR) is an autosomal dominant hereditary disease that occurs due to deposition of variant TTR (transthyretin) protein in humans. It is mainly characterized into two main types i.e. Hereditary ATTR (hATTR) and Wild-Type (wt) ATTR. While Hereditary ATTR is caused by point mutations within TTR allele, wild-type ATTR is caused by the misfolding of Wild-Type TTR. Major prevalence of Hereditary ATTR is observed in the 7MM, and this type has been further sub-classified into Familial Amyloidosis Polyneuropathy (FAP) and Familial Amyloidosis Cardiomyopathy (FAC).
The global Transthyretin Amyloidosis (Attr) market size was estimated at USD 3580.42 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Transthyretin Amyloidosis (Attr) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Transthyretin Amyloidosis (Attr) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Transthyretin Amyloidosis (Attr) market
Global Transthyretin Amyloidosis (Attr) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Corino Therapeutics
Proclara Bioscience
Arcturus Therapeutics
Market Segmentation (by Type)
Hereditary ATTR (HATTR)
Wild-Type (WT) ATTR
Market Segmentation (by Application)
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Transthyretin Amyloidosis (Attr) Market
- Overview of the regional outlook of the Transthyretin Amyloidosis (Attr) Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Transthyretin Amyloidosis (Attr) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Transthyretin Amyloidosis (Attr), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Transthyretin Amyloidosis (Attr)
1.2 Key Market Segments
1.2.1 Transthyretin Amyloidosis (Attr) Segment by Type
1.2.2 Transthyretin Amyloidosis (Attr) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Transthyretin Amyloidosis (Attr) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Transthyretin Amyloidosis (Attr) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Transthyretin Amyloidosis (Attr) Product Life Cycle
3.3 Global Transthyretin Amyloidosis (Attr) Sales by Manufacturers (2020-2025)
3.4 Global Transthyretin Amyloidosis (Attr) Revenue Market Share by Manufacturers (2020-2025)
3.5 Transthyretin Amyloidosis (Attr) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Transthyretin Amyloidosis (Attr) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Transthyretin Amyloidosis (Attr) Market Competitive Situation and Trends
3.8.1 Transthyretin Amyloidosis (Attr) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Transthyretin Amyloidosis (Attr) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TRANSTHYRETIN AMYLOIDOSIS (ATTR) INDUSTRY CHAIN ANALYSIS
4.1 Transthyretin Amyloidosis (Attr) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Transthyretin Amyloidosis (Attr) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Transthyretin Amyloidosis (Attr) Market
5.7 ESG Ratings of Leading Companies
6 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Transthyretin Amyloidosis (Attr) Sales Market Share by Type (2020-2025)
6.3 Global Transthyretin Amyloidosis (Attr) Market Size Market Share by Type (2020-2025)
6.4 Global Transthyretin Amyloidosis (Attr) Price by Type (2020-2025)
7 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Transthyretin Amyloidosis (Attr) Market Sales by Application (2020-2025)
7.3 Global Transthyretin Amyloidosis (Attr) Market Size (M USD) by Application (2020-2025)
7.4 Global Transthyretin Amyloidosis (Attr) Sales Growth Rate by Application (2020-2025)
8 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET SALES BY REGION
8.1 Global Transthyretin Amyloidosis (Attr) Sales by Region
8.1.1 Global Transthyretin Amyloidosis (Attr) Sales by Region
8.1.2 Global Transthyretin Amyloidosis (Attr) Sales Market Share by Region
8.2 Global Transthyretin Amyloidosis (Attr) Market Size by Region
8.2.1 Global Transthyretin Amyloidosis (Attr) Market Size by Region
8.2.2 Global Transthyretin Amyloidosis (Attr) Market Size Market Share by Region
8.3 North America
8.3.1 North America Transthyretin Amyloidosis (Attr) Sales by Country
8.3.2 North America Transthyretin Amyloidosis (Attr) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Transthyretin Amyloidosis (Attr) Sales by Country
8.4.2 Europe Transthyretin Amyloidosis (Attr) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Transthyretin Amyloidosis (Attr) Sales by Region
8.5.2 Asia Pacific Transthyretin Amyloidosis (Attr) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Transthyretin Amyloidosis (Attr) Sales by Country
8.6.2 South America Transthyretin Amyloidosis (Attr) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Transthyretin Amyloidosis (Attr) Sales by Region
8.7.2 Middle East and Africa Transthyretin Amyloidosis (Attr) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET PRODUCTION BY REGION
9.1 Global Production of Transthyretin Amyloidosis (Attr) by Region(2020-2025)
9.2 Global Transthyretin Amyloidosis (Attr) Revenue Market Share by Region (2020-2025)
9.3 Global Transthyretin Amyloidosis (Attr) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Transthyretin Amyloidosis (Attr) Production
9.4.1 North America Transthyretin Amyloidosis (Attr) Production Growth Rate (2020-2025)
9.4.2 North America Transthyretin Amyloidosis (Attr) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Transthyretin Amyloidosis (Attr) Production
9.5.1 Europe Transthyretin Amyloidosis (Attr) Production Growth Rate (2020-2025)
9.5.2 Europe Transthyretin Amyloidosis (Attr) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Transthyretin Amyloidosis (Attr) Production (2020-2025)
9.6.1 Japan Transthyretin Amyloidosis (Attr) Production Growth Rate (2020-2025)
9.6.2 Japan Transthyretin Amyloidosis (Attr) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Transthyretin Amyloidosis (Attr) Production (2020-2025)
9.7.1 China Transthyretin Amyloidosis (Attr) Production Growth Rate (2020-2025)
9.7.2 China Transthyretin Amyloidosis (Attr) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Transthyretin Amyloidosis (Attr) Product Overview
10.1.3 Pfizer Transthyretin Amyloidosis (Attr) Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Alnylam Pharmaceuticals
10.2.1 Alnylam Pharmaceuticals Basic Information
10.2.2 Alnylam Pharmaceuticals Transthyretin Amyloidosis (Attr) Product Overview
10.2.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (Attr) Product Market Performance
10.2.4 Alnylam Pharmaceuticals Business Overview
10.2.5 Alnylam Pharmaceuticals SWOT Analysis
10.2.6 Alnylam Pharmaceuticals Recent Developments
10.3 Ionis Pharmaceuticals
10.3.1 Ionis Pharmaceuticals Basic Information
10.3.2 Ionis Pharmaceuticals Transthyretin Amyloidosis (Attr) Product Overview
10.3.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (Attr) Product Market Performance
10.3.4 Ionis Pharmaceuticals Business Overview
10.3.5 Ionis Pharmaceuticals SWOT Analysis
10.3.6 Ionis Pharmaceuticals Recent Developments
10.4 Corino Therapeutics
10.4.1 Corino Therapeutics Basic Information
10.4.2 Corino Therapeutics Transthyretin Amyloidosis (Attr) Product Overview
10.4.3 Corino Therapeutics Transthyretin Amyloidosis (Attr) Product Market Performance
10.4.4 Corino Therapeutics Business Overview
10.4.5 Corino Therapeutics Recent Developments
10.5 Proclara Bioscience
10.5.1 Proclara Bioscience Basic Information
10.5.2 Proclara Bioscience Transthyretin Amyloidosis (Attr) Product Overview
10.5.3 Proclara Bioscience Transthyretin Amyloidosis (Attr) Product Market Performance
10.5.4 Proclara Bioscience Business Overview
10.5.5 Proclara Bioscience Recent Developments
10.6 Arcturus Therapeutics
10.6.1 Arcturus Therapeutics Basic Information
10.6.2 Arcturus Therapeutics Transthyretin Amyloidosis (Attr) Product Overview
10.6.3 Arcturus Therapeutics Transthyretin Amyloidosis (Attr) Product Market Performance
10.6.4 Arcturus Therapeutics Business Overview
10.6.5 Arcturus Therapeutics Recent Developments
11 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET FORECAST BY REGION
11.1 Global Transthyretin Amyloidosis (Attr) Market Size Forecast
11.2 Global Transthyretin Amyloidosis (Attr) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Transthyretin Amyloidosis (Attr) Market Size Forecast by Country
11.2.3 Asia Pacific Transthyretin Amyloidosis (Attr) Market Size Forecast by Region
11.2.4 South America Transthyretin Amyloidosis (Attr) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Transthyretin Amyloidosis (Attr) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Transthyretin Amyloidosis (Attr) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Transthyretin Amyloidosis (Attr) by Type (2026-2033)
12.1.2 Global Transthyretin Amyloidosis (Attr) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Transthyretin Amyloidosis (Attr) by Type (2026-2033)
12.2 Global Transthyretin Amyloidosis (Attr) Market Forecast by Application (2026-2033)
12.2.1 Global Transthyretin Amyloidosis (Attr) Sales (K Units) Forecast by Application
12.2.2 Global Transthyretin Amyloidosis (Attr) Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Transthyretin Amyloidosis (Attr)
1.2 Key Market Segments
1.2.1 Transthyretin Amyloidosis (Attr) Segment by Type
1.2.2 Transthyretin Amyloidosis (Attr) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Transthyretin Amyloidosis (Attr) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Transthyretin Amyloidosis (Attr) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Transthyretin Amyloidosis (Attr) Product Life Cycle
3.3 Global Transthyretin Amyloidosis (Attr) Sales by Manufacturers (2020-2025)
3.4 Global Transthyretin Amyloidosis (Attr) Revenue Market Share by Manufacturers (2020-2025)
3.5 Transthyretin Amyloidosis (Attr) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Transthyretin Amyloidosis (Attr) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Transthyretin Amyloidosis (Attr) Market Competitive Situation and Trends
3.8.1 Transthyretin Amyloidosis (Attr) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Transthyretin Amyloidosis (Attr) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TRANSTHYRETIN AMYLOIDOSIS (ATTR) INDUSTRY CHAIN ANALYSIS
4.1 Transthyretin Amyloidosis (Attr) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Transthyretin Amyloidosis (Attr) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Transthyretin Amyloidosis (Attr) Market
5.7 ESG Ratings of Leading Companies
6 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Transthyretin Amyloidosis (Attr) Sales Market Share by Type (2020-2025)
6.3 Global Transthyretin Amyloidosis (Attr) Market Size Market Share by Type (2020-2025)
6.4 Global Transthyretin Amyloidosis (Attr) Price by Type (2020-2025)
7 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Transthyretin Amyloidosis (Attr) Market Sales by Application (2020-2025)
7.3 Global Transthyretin Amyloidosis (Attr) Market Size (M USD) by Application (2020-2025)
7.4 Global Transthyretin Amyloidosis (Attr) Sales Growth Rate by Application (2020-2025)
8 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET SALES BY REGION
8.1 Global Transthyretin Amyloidosis (Attr) Sales by Region
8.1.1 Global Transthyretin Amyloidosis (Attr) Sales by Region
8.1.2 Global Transthyretin Amyloidosis (Attr) Sales Market Share by Region
8.2 Global Transthyretin Amyloidosis (Attr) Market Size by Region
8.2.1 Global Transthyretin Amyloidosis (Attr) Market Size by Region
8.2.2 Global Transthyretin Amyloidosis (Attr) Market Size Market Share by Region
8.3 North America
8.3.1 North America Transthyretin Amyloidosis (Attr) Sales by Country
8.3.2 North America Transthyretin Amyloidosis (Attr) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Transthyretin Amyloidosis (Attr) Sales by Country
8.4.2 Europe Transthyretin Amyloidosis (Attr) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Transthyretin Amyloidosis (Attr) Sales by Region
8.5.2 Asia Pacific Transthyretin Amyloidosis (Attr) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Transthyretin Amyloidosis (Attr) Sales by Country
8.6.2 South America Transthyretin Amyloidosis (Attr) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Transthyretin Amyloidosis (Attr) Sales by Region
8.7.2 Middle East and Africa Transthyretin Amyloidosis (Attr) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET PRODUCTION BY REGION
9.1 Global Production of Transthyretin Amyloidosis (Attr) by Region(2020-2025)
9.2 Global Transthyretin Amyloidosis (Attr) Revenue Market Share by Region (2020-2025)
9.3 Global Transthyretin Amyloidosis (Attr) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Transthyretin Amyloidosis (Attr) Production
9.4.1 North America Transthyretin Amyloidosis (Attr) Production Growth Rate (2020-2025)
9.4.2 North America Transthyretin Amyloidosis (Attr) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Transthyretin Amyloidosis (Attr) Production
9.5.1 Europe Transthyretin Amyloidosis (Attr) Production Growth Rate (2020-2025)
9.5.2 Europe Transthyretin Amyloidosis (Attr) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Transthyretin Amyloidosis (Attr) Production (2020-2025)
9.6.1 Japan Transthyretin Amyloidosis (Attr) Production Growth Rate (2020-2025)
9.6.2 Japan Transthyretin Amyloidosis (Attr) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Transthyretin Amyloidosis (Attr) Production (2020-2025)
9.7.1 China Transthyretin Amyloidosis (Attr) Production Growth Rate (2020-2025)
9.7.2 China Transthyretin Amyloidosis (Attr) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Transthyretin Amyloidosis (Attr) Product Overview
10.1.3 Pfizer Transthyretin Amyloidosis (Attr) Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Alnylam Pharmaceuticals
10.2.1 Alnylam Pharmaceuticals Basic Information
10.2.2 Alnylam Pharmaceuticals Transthyretin Amyloidosis (Attr) Product Overview
10.2.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (Attr) Product Market Performance
10.2.4 Alnylam Pharmaceuticals Business Overview
10.2.5 Alnylam Pharmaceuticals SWOT Analysis
10.2.6 Alnylam Pharmaceuticals Recent Developments
10.3 Ionis Pharmaceuticals
10.3.1 Ionis Pharmaceuticals Basic Information
10.3.2 Ionis Pharmaceuticals Transthyretin Amyloidosis (Attr) Product Overview
10.3.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (Attr) Product Market Performance
10.3.4 Ionis Pharmaceuticals Business Overview
10.3.5 Ionis Pharmaceuticals SWOT Analysis
10.3.6 Ionis Pharmaceuticals Recent Developments
10.4 Corino Therapeutics
10.4.1 Corino Therapeutics Basic Information
10.4.2 Corino Therapeutics Transthyretin Amyloidosis (Attr) Product Overview
10.4.3 Corino Therapeutics Transthyretin Amyloidosis (Attr) Product Market Performance
10.4.4 Corino Therapeutics Business Overview
10.4.5 Corino Therapeutics Recent Developments
10.5 Proclara Bioscience
10.5.1 Proclara Bioscience Basic Information
10.5.2 Proclara Bioscience Transthyretin Amyloidosis (Attr) Product Overview
10.5.3 Proclara Bioscience Transthyretin Amyloidosis (Attr) Product Market Performance
10.5.4 Proclara Bioscience Business Overview
10.5.5 Proclara Bioscience Recent Developments
10.6 Arcturus Therapeutics
10.6.1 Arcturus Therapeutics Basic Information
10.6.2 Arcturus Therapeutics Transthyretin Amyloidosis (Attr) Product Overview
10.6.3 Arcturus Therapeutics Transthyretin Amyloidosis (Attr) Product Market Performance
10.6.4 Arcturus Therapeutics Business Overview
10.6.5 Arcturus Therapeutics Recent Developments
11 TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET FORECAST BY REGION
11.1 Global Transthyretin Amyloidosis (Attr) Market Size Forecast
11.2 Global Transthyretin Amyloidosis (Attr) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Transthyretin Amyloidosis (Attr) Market Size Forecast by Country
11.2.3 Asia Pacific Transthyretin Amyloidosis (Attr) Market Size Forecast by Region
11.2.4 South America Transthyretin Amyloidosis (Attr) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Transthyretin Amyloidosis (Attr) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Transthyretin Amyloidosis (Attr) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Transthyretin Amyloidosis (Attr) by Type (2026-2033)
12.1.2 Global Transthyretin Amyloidosis (Attr) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Transthyretin Amyloidosis (Attr) by Type (2026-2033)
12.2 Global Transthyretin Amyloidosis (Attr) Market Forecast by Application (2026-2033)
12.2.1 Global Transthyretin Amyloidosis (Attr) Sales (K Units) Forecast by Application
12.2.2 Global Transthyretin Amyloidosis (Attr) Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Transthyretin Amyloidosis (Attr) Market Size Comparison by Region (M USD)
Table 5. Global Transthyretin Amyloidosis (Attr) Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Transthyretin Amyloidosis (Attr) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Transthyretin Amyloidosis (Attr) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis (Attr) as of 2024)
Table 10. Global Market Transthyretin Amyloidosis (Attr) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Transthyretin Amyloidosis (Attr) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Transthyretin Amyloidosis (Attr) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Transthyretin Amyloidosis (Attr) Sales by Type (K Units)
Table 26. Global Transthyretin Amyloidosis (Attr) Market Size by Type (M USD)
Table 27. Global Transthyretin Amyloidosis (Attr) Sales (K Units) by Type (2020-2025)
Table 28. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Type (2020-2025)
Table 29. Global Transthyretin Amyloidosis (Attr) Market Size (M USD) by Type (2020-2025)
Table 30. Global Transthyretin Amyloidosis (Attr) Market Size Share by Type (2020-2025)
Table 31. Global Transthyretin Amyloidosis (Attr) Price (USD/Unit) by Type (2020-2025)
Table 32. Global Transthyretin Amyloidosis (Attr) Sales (K Units) by Application
Table 33. Global Transthyretin Amyloidosis (Attr) Market Size by Application
Table 34. Global Transthyretin Amyloidosis (Attr) Sales by Application (2020-2025) & (K Units)
Table 35. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Application (2020-2025)
Table 36. Global Transthyretin Amyloidosis (Attr) Market Size by Application (2020-2025) & (M USD)
Table 37. Global Transthyretin Amyloidosis (Attr) Market Share by Application (2020-2025)
Table 38. Global Transthyretin Amyloidosis (Attr) Sales Growth Rate by Application (2020-2025)
Table 39. Global Transthyretin Amyloidosis (Attr) Sales by Region (2020-2025) & (K Units)
Table 40. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Region (2020-2025)
Table 41. Global Transthyretin Amyloidosis (Attr) Market Size by Region (2020-2025) & (M USD)
Table 42. Global Transthyretin Amyloidosis (Attr) Market Size Market Share by Region (2020-2025)
Table 43. North America Transthyretin Amyloidosis (Attr) Sales by Country (2020-2025) & (K Units)
Table 44. North America Transthyretin Amyloidosis (Attr) Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Transthyretin Amyloidosis (Attr) Sales by Country (2020-2025) & (K Units)
Table 46. Europe Transthyretin Amyloidosis (Attr) Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Transthyretin Amyloidosis (Attr) Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Transthyretin Amyloidosis (Attr) Market Size by Region (2020-2025) & (M USD)
Table 49. South America Transthyretin Amyloidosis (Attr) Sales by Country (2020-2025) & (K Units)
Table 50. South America Transthyretin Amyloidosis (Attr) Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Transthyretin Amyloidosis (Attr) Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Transthyretin Amyloidosis (Attr) Market Size by Region (2020-2025) & (M USD)
Table 53. Global Transthyretin Amyloidosis (Attr) Production (K Units) by Region(2020-2025)
Table 54. Global Transthyretin Amyloidosis (Attr) Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Transthyretin Amyloidosis (Attr) Revenue Market Share by Region (2020-2025)
Table 56. Global Transthyretin Amyloidosis (Attr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Transthyretin Amyloidosis (Attr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Transthyretin Amyloidosis (Attr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Transthyretin Amyloidosis (Attr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Transthyretin Amyloidosis (Attr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Pfizer Basic Information
Table 62. Pfizer Transthyretin Amyloidosis (Attr) Product Overview
Table 63. Pfizer Transthyretin Amyloidosis (Attr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Pfizer Business Overview
Table 65. Pfizer SWOT Analysis
Table 66. Pfizer Recent Developments
Table 67. Alnylam Pharmaceuticals Basic Information
Table 68. Alnylam Pharmaceuticals Transthyretin Amyloidosis (Attr) Product Overview
Table 69. Alnylam Pharmaceuticals Transthyretin Amyloidosis (Attr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Alnylam Pharmaceuticals Business Overview
Table 71. Alnylam Pharmaceuticals SWOT Analysis
Table 72. Alnylam Pharmaceuticals Recent Developments
Table 73. Ionis Pharmaceuticals Basic Information
Table 74. Ionis Pharmaceuticals Transthyretin Amyloidosis (Attr) Product Overview
Table 75. Ionis Pharmaceuticals Transthyretin Amyloidosis (Attr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Ionis Pharmaceuticals Business Overview
Table 77. Ionis Pharmaceuticals SWOT Analysis
Table 78. Ionis Pharmaceuticals Recent Developments
Table 79. Corino Therapeutics Basic Information
Table 80. Corino Therapeutics Transthyretin Amyloidosis (Attr) Product Overview
Table 81. Corino Therapeutics Transthyretin Amyloidosis (Attr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Corino Therapeutics Business Overview
Table 83. Corino Therapeutics Recent Developments
Table 84. Proclara Bioscience Basic Information
Table 85. Proclara Bioscience Transthyretin Amyloidosis (Attr) Product Overview
Table 86. Proclara Bioscience Transthyretin Amyloidosis (Attr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Proclara Bioscience Business Overview
Table 88. Proclara Bioscience Recent Developments
Table 89. Arcturus Therapeutics Basic Information
Table 90. Arcturus Therapeutics Transthyretin Amyloidosis (Attr) Product Overview
Table 91. Arcturus Therapeutics Transthyretin Amyloidosis (Attr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Arcturus Therapeutics Business Overview
Table 93. Arcturus Therapeutics Recent Developments
Table 94. Global Transthyretin Amyloidosis (Attr) Sales Forecast by Region (2026-2033) & (K Units)
Table 95. Global Transthyretin Amyloidosis (Attr) Market Size Forecast by Region (2026-2033) & (M USD)
Table 96. North America Transthyretin Amyloidosis (Attr) Sales Forecast by Country (2026-2033) & (K Units)
Table 97. North America Transthyretin Amyloidosis (Attr) Market Size Forecast by Country (2026-2033) & (M USD)
Table 98. Europe Transthyretin Amyloidosis (Attr) Sales Forecast by Country (2026-2033) & (K Units)
Table 99. Europe Transthyretin Amyloidosis (Attr) Market Size Forecast by Country (2026-2033) & (M USD)
Table 100. Asia Pacific Transthyretin Amyloidosis (Attr) Sales Forecast by Region (2026-2033) & (K Units)
Table 101. Asia Pacific Transthyretin Amyloidosis (Attr) Market Size Forecast by Region (2026-2033) & (M USD)
Table 102. South America Transthyretin Amyloidosis (Attr) Sales Forecast by Country (2026-2033) & (K Units)
Table 103. South America Transthyretin Amyloidosis (Attr) Market Size Forecast by Country (2026-2033) & (M USD)
Table 104. Middle East and Africa Transthyretin Amyloidosis (Attr) Sales Forecast by Country (2026-2033) & (Units)
Table 105. Middle East and Africa Transthyretin Amyloidosis (Attr) Market Size Forecast by Country (2026-2033) & (M USD)
Table 106. Global Transthyretin Amyloidosis (Attr) Sales Forecast by Type (2026-2033) & (K Units)
Table 107. Global Transthyretin Amyloidosis (Attr) Market Size Forecast by Type (2026-2033) & (M USD)
Table 108. Global Transthyretin Amyloidosis (Attr) Price Forecast by Type (2026-2033) & (USD/Unit)
Table 109. Global Transthyretin Amyloidosis (Attr) Sales (K Units) Forecast by Application (2026-2033)
Table 110. Global Transthyretin Amyloidosis (Attr) Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Transthyretin Amyloidosis (Attr) Market Size Comparison by Region (M USD)
Table 5. Global Transthyretin Amyloidosis (Attr) Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Transthyretin Amyloidosis (Attr) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Transthyretin Amyloidosis (Attr) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis (Attr) as of 2024)
Table 10. Global Market Transthyretin Amyloidosis (Attr) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Transthyretin Amyloidosis (Attr) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Transthyretin Amyloidosis (Attr) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Transthyretin Amyloidosis (Attr) Sales by Type (K Units)
Table 26. Global Transthyretin Amyloidosis (Attr) Market Size by Type (M USD)
Table 27. Global Transthyretin Amyloidosis (Attr) Sales (K Units) by Type (2020-2025)
Table 28. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Type (2020-2025)
Table 29. Global Transthyretin Amyloidosis (Attr) Market Size (M USD) by Type (2020-2025)
Table 30. Global Transthyretin Amyloidosis (Attr) Market Size Share by Type (2020-2025)
Table 31. Global Transthyretin Amyloidosis (Attr) Price (USD/Unit) by Type (2020-2025)
Table 32. Global Transthyretin Amyloidosis (Attr) Sales (K Units) by Application
Table 33. Global Transthyretin Amyloidosis (Attr) Market Size by Application
Table 34. Global Transthyretin Amyloidosis (Attr) Sales by Application (2020-2025) & (K Units)
Table 35. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Application (2020-2025)
Table 36. Global Transthyretin Amyloidosis (Attr) Market Size by Application (2020-2025) & (M USD)
Table 37. Global Transthyretin Amyloidosis (Attr) Market Share by Application (2020-2025)
Table 38. Global Transthyretin Amyloidosis (Attr) Sales Growth Rate by Application (2020-2025)
Table 39. Global Transthyretin Amyloidosis (Attr) Sales by Region (2020-2025) & (K Units)
Table 40. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Region (2020-2025)
Table 41. Global Transthyretin Amyloidosis (Attr) Market Size by Region (2020-2025) & (M USD)
Table 42. Global Transthyretin Amyloidosis (Attr) Market Size Market Share by Region (2020-2025)
Table 43. North America Transthyretin Amyloidosis (Attr) Sales by Country (2020-2025) & (K Units)
Table 44. North America Transthyretin Amyloidosis (Attr) Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Transthyretin Amyloidosis (Attr) Sales by Country (2020-2025) & (K Units)
Table 46. Europe Transthyretin Amyloidosis (Attr) Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Transthyretin Amyloidosis (Attr) Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Transthyretin Amyloidosis (Attr) Market Size by Region (2020-2025) & (M USD)
Table 49. South America Transthyretin Amyloidosis (Attr) Sales by Country (2020-2025) & (K Units)
Table 50. South America Transthyretin Amyloidosis (Attr) Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Transthyretin Amyloidosis (Attr) Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Transthyretin Amyloidosis (Attr) Market Size by Region (2020-2025) & (M USD)
Table 53. Global Transthyretin Amyloidosis (Attr) Production (K Units) by Region(2020-2025)
Table 54. Global Transthyretin Amyloidosis (Attr) Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Transthyretin Amyloidosis (Attr) Revenue Market Share by Region (2020-2025)
Table 56. Global Transthyretin Amyloidosis (Attr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Transthyretin Amyloidosis (Attr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Transthyretin Amyloidosis (Attr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Transthyretin Amyloidosis (Attr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Transthyretin Amyloidosis (Attr) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Pfizer Basic Information
Table 62. Pfizer Transthyretin Amyloidosis (Attr) Product Overview
Table 63. Pfizer Transthyretin Amyloidosis (Attr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Pfizer Business Overview
Table 65. Pfizer SWOT Analysis
Table 66. Pfizer Recent Developments
Table 67. Alnylam Pharmaceuticals Basic Information
Table 68. Alnylam Pharmaceuticals Transthyretin Amyloidosis (Attr) Product Overview
Table 69. Alnylam Pharmaceuticals Transthyretin Amyloidosis (Attr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Alnylam Pharmaceuticals Business Overview
Table 71. Alnylam Pharmaceuticals SWOT Analysis
Table 72. Alnylam Pharmaceuticals Recent Developments
Table 73. Ionis Pharmaceuticals Basic Information
Table 74. Ionis Pharmaceuticals Transthyretin Amyloidosis (Attr) Product Overview
Table 75. Ionis Pharmaceuticals Transthyretin Amyloidosis (Attr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Ionis Pharmaceuticals Business Overview
Table 77. Ionis Pharmaceuticals SWOT Analysis
Table 78. Ionis Pharmaceuticals Recent Developments
Table 79. Corino Therapeutics Basic Information
Table 80. Corino Therapeutics Transthyretin Amyloidosis (Attr) Product Overview
Table 81. Corino Therapeutics Transthyretin Amyloidosis (Attr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Corino Therapeutics Business Overview
Table 83. Corino Therapeutics Recent Developments
Table 84. Proclara Bioscience Basic Information
Table 85. Proclara Bioscience Transthyretin Amyloidosis (Attr) Product Overview
Table 86. Proclara Bioscience Transthyretin Amyloidosis (Attr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Proclara Bioscience Business Overview
Table 88. Proclara Bioscience Recent Developments
Table 89. Arcturus Therapeutics Basic Information
Table 90. Arcturus Therapeutics Transthyretin Amyloidosis (Attr) Product Overview
Table 91. Arcturus Therapeutics Transthyretin Amyloidosis (Attr) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Arcturus Therapeutics Business Overview
Table 93. Arcturus Therapeutics Recent Developments
Table 94. Global Transthyretin Amyloidosis (Attr) Sales Forecast by Region (2026-2033) & (K Units)
Table 95. Global Transthyretin Amyloidosis (Attr) Market Size Forecast by Region (2026-2033) & (M USD)
Table 96. North America Transthyretin Amyloidosis (Attr) Sales Forecast by Country (2026-2033) & (K Units)
Table 97. North America Transthyretin Amyloidosis (Attr) Market Size Forecast by Country (2026-2033) & (M USD)
Table 98. Europe Transthyretin Amyloidosis (Attr) Sales Forecast by Country (2026-2033) & (K Units)
Table 99. Europe Transthyretin Amyloidosis (Attr) Market Size Forecast by Country (2026-2033) & (M USD)
Table 100. Asia Pacific Transthyretin Amyloidosis (Attr) Sales Forecast by Region (2026-2033) & (K Units)
Table 101. Asia Pacific Transthyretin Amyloidosis (Attr) Market Size Forecast by Region (2026-2033) & (M USD)
Table 102. South America Transthyretin Amyloidosis (Attr) Sales Forecast by Country (2026-2033) & (K Units)
Table 103. South America Transthyretin Amyloidosis (Attr) Market Size Forecast by Country (2026-2033) & (M USD)
Table 104. Middle East and Africa Transthyretin Amyloidosis (Attr) Sales Forecast by Country (2026-2033) & (Units)
Table 105. Middle East and Africa Transthyretin Amyloidosis (Attr) Market Size Forecast by Country (2026-2033) & (M USD)
Table 106. Global Transthyretin Amyloidosis (Attr) Sales Forecast by Type (2026-2033) & (K Units)
Table 107. Global Transthyretin Amyloidosis (Attr) Market Size Forecast by Type (2026-2033) & (M USD)
Table 108. Global Transthyretin Amyloidosis (Attr) Price Forecast by Type (2026-2033) & (USD/Unit)
Table 109. Global Transthyretin Amyloidosis (Attr) Sales (K Units) Forecast by Application (2026-2033)
Table 110. Global Transthyretin Amyloidosis (Attr) Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Transthyretin Amyloidosis (Attr)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Transthyretin Amyloidosis (Attr) Market Size (M USD), 2024-2033
Figure 5. Global Transthyretin Amyloidosis (Attr) Market Size (M USD) (2020-2033)
Figure 6. Global Transthyretin Amyloidosis (Attr) Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Transthyretin Amyloidosis (Attr) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Transthyretin Amyloidosis (Attr) Product Life Cycle
Figure 13. Transthyretin Amyloidosis (Attr) Sales Share by Manufacturers in 2024
Figure 14. Global Transthyretin Amyloidosis (Attr) Revenue Share by Manufacturers in 2024
Figure 15. Transthyretin Amyloidosis (Attr) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Transthyretin Amyloidosis (Attr) Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Transthyretin Amyloidosis (Attr) Revenue in 2024
Figure 18. Industry Chain Map of Transthyretin Amyloidosis (Attr)
Figure 19. Global Transthyretin Amyloidosis (Attr) Market PEST Analysis
Figure 20. Global Transthyretin Amyloidosis (Attr) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Transthyretin Amyloidosis (Attr) Market Share by Type
Figure 27. Sales Market Share of Transthyretin Amyloidosis (Attr) by Type (2020-2025)
Figure 28. Sales Market Share of Transthyretin Amyloidosis (Attr) by Type in 2024
Figure 29. Market Size Share of Transthyretin Amyloidosis (Attr) by Type (2020-2025)
Figure 30. Market Size Share of Transthyretin Amyloidosis (Attr) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Transthyretin Amyloidosis (Attr) Market Share by Application
Figure 33. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Application (2020-2025)
Figure 34. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Application in 2024
Figure 35. Global Transthyretin Amyloidosis (Attr) Market Share by Application (2020-2025)
Figure 36. Global Transthyretin Amyloidosis (Attr) Market Share by Application in 2024
Figure 37. Global Transthyretin Amyloidosis (Attr) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Region (2020-2025)
Figure 39. Global Transthyretin Amyloidosis (Attr) Market Size Market Share by Region (2020-2025)
Figure 40. North America Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Transthyretin Amyloidosis (Attr) Sales Market Share by Country in 2024
Figure 43. North America Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Transthyretin Amyloidosis (Attr) Market Size Market Share by Country in 2024
Figure 45. U.S. Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Transthyretin Amyloidosis (Attr) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Transthyretin Amyloidosis (Attr) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Transthyretin Amyloidosis (Attr) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Transthyretin Amyloidosis (Attr) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Transthyretin Amyloidosis (Attr) Sales Market Share by Country in 2024
Figure 53. Europe Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Transthyretin Amyloidosis (Attr) Market Size Market Share by Country in 2024
Figure 55. Germany Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Transthyretin Amyloidosis (Attr) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Transthyretin Amyloidosis (Attr) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Transthyretin Amyloidosis (Attr) Market Size Market Share by Region in 2024
Figure 68. China Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Transthyretin Amyloidosis (Attr) Sales and Growth Rate (K Units)
Figure 79. South America Transthyretin Amyloidosis (Attr) Sales Market Share by Country in 2024
Figure 80. South America Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (M USD)
Figure 81. South America Transthyretin Amyloidosis (Attr) Market Size Market Share by Country in 2024
Figure 82. Brazil Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Transthyretin Amyloidosis (Attr) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Transthyretin Amyloidosis (Attr) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Transthyretin Amyloidosis (Attr) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Transthyretin Amyloidosis (Attr) Production Market Share by Region (2020-2025)
Figure 103. North America Transthyretin Amyloidosis (Attr) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Transthyretin Amyloidosis (Attr) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Transthyretin Amyloidosis (Attr) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Transthyretin Amyloidosis (Attr) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Transthyretin Amyloidosis (Attr) Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Transthyretin Amyloidosis (Attr) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Transthyretin Amyloidosis (Attr) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Transthyretin Amyloidosis (Attr) Market Share Forecast by Type (2026-2033)
Figure 111. Global Transthyretin Amyloidosis (Attr) Sales Forecast by Application (2026-2033)
Figure 112. Global Transthyretin Amyloidosis (Attr) Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Transthyretin Amyloidosis (Attr)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Transthyretin Amyloidosis (Attr) Market Size (M USD), 2024-2033
Figure 5. Global Transthyretin Amyloidosis (Attr) Market Size (M USD) (2020-2033)
Figure 6. Global Transthyretin Amyloidosis (Attr) Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Transthyretin Amyloidosis (Attr) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Transthyretin Amyloidosis (Attr) Product Life Cycle
Figure 13. Transthyretin Amyloidosis (Attr) Sales Share by Manufacturers in 2024
Figure 14. Global Transthyretin Amyloidosis (Attr) Revenue Share by Manufacturers in 2024
Figure 15. Transthyretin Amyloidosis (Attr) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Transthyretin Amyloidosis (Attr) Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Transthyretin Amyloidosis (Attr) Revenue in 2024
Figure 18. Industry Chain Map of Transthyretin Amyloidosis (Attr)
Figure 19. Global Transthyretin Amyloidosis (Attr) Market PEST Analysis
Figure 20. Global Transthyretin Amyloidosis (Attr) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Transthyretin Amyloidosis (Attr) Market Share by Type
Figure 27. Sales Market Share of Transthyretin Amyloidosis (Attr) by Type (2020-2025)
Figure 28. Sales Market Share of Transthyretin Amyloidosis (Attr) by Type in 2024
Figure 29. Market Size Share of Transthyretin Amyloidosis (Attr) by Type (2020-2025)
Figure 30. Market Size Share of Transthyretin Amyloidosis (Attr) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Transthyretin Amyloidosis (Attr) Market Share by Application
Figure 33. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Application (2020-2025)
Figure 34. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Application in 2024
Figure 35. Global Transthyretin Amyloidosis (Attr) Market Share by Application (2020-2025)
Figure 36. Global Transthyretin Amyloidosis (Attr) Market Share by Application in 2024
Figure 37. Global Transthyretin Amyloidosis (Attr) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Transthyretin Amyloidosis (Attr) Sales Market Share by Region (2020-2025)
Figure 39. Global Transthyretin Amyloidosis (Attr) Market Size Market Share by Region (2020-2025)
Figure 40. North America Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Transthyretin Amyloidosis (Attr) Sales Market Share by Country in 2024
Figure 43. North America Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Transthyretin Amyloidosis (Attr) Market Size Market Share by Country in 2024
Figure 45. U.S. Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Transthyretin Amyloidosis (Attr) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Transthyretin Amyloidosis (Attr) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Transthyretin Amyloidosis (Attr) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Transthyretin Amyloidosis (Attr) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Transthyretin Amyloidosis (Attr) Sales Market Share by Country in 2024
Figure 53. Europe Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Transthyretin Amyloidosis (Attr) Market Size Market Share by Country in 2024
Figure 55. Germany Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Transthyretin Amyloidosis (Attr) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Transthyretin Amyloidosis (Attr) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Transthyretin Amyloidosis (Attr) Market Size Market Share by Region in 2024
Figure 68. China Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Transthyretin Amyloidosis (Attr) Sales and Growth Rate (K Units)
Figure 79. South America Transthyretin Amyloidosis (Attr) Sales Market Share by Country in 2024
Figure 80. South America Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (M USD)
Figure 81. South America Transthyretin Amyloidosis (Attr) Market Size Market Share by Country in 2024
Figure 82. Brazil Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Transthyretin Amyloidosis (Attr) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Transthyretin Amyloidosis (Attr) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Transthyretin Amyloidosis (Attr) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Transthyretin Amyloidosis (Attr) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Transthyretin Amyloidosis (Attr) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Transthyretin Amyloidosis (Attr) Production Market Share by Region (2020-2025)
Figure 103. North America Transthyretin Amyloidosis (Attr) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Transthyretin Amyloidosis (Attr) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Transthyretin Amyloidosis (Attr) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Transthyretin Amyloidosis (Attr) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Transthyretin Amyloidosis (Attr) Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Transthyretin Amyloidosis (Attr) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Transthyretin Amyloidosis (Attr) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Transthyretin Amyloidosis (Attr) Market Share Forecast by Type (2026-2033)
Figure 111. Global Transthyretin Amyloidosis (Attr) Sales Forecast by Application (2026-2033)
Figure 112. Global Transthyretin Amyloidosis (Attr) Market Share Forecast by Application (2026-2033)
